6 results
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
compared the study treatment ... with ‘treatment ... for inclusion all ... EBM #Management #Pharmacology ... #Medications #Pharmacotherapy
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... getting patients on medication ... recommended by the ACC ... HeartFailure #HFrEF #Pharmacology ... #StageC #Cardiology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Syndrome (PRES) Overview ... circulation: MCA ACA ... Electrolyte abnormality, Medication ... epilepticus Treatment ... underlying cause • Treatment
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Inhibitors of Na+K+2Cl ... specific bleeding disorders ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology ... #Medications #Table
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
and diuretics all ... Lithium is a medication ... maintenance agent for treatment ... #BPD #Toxicity ... #Pharmacology #Psychiatry
Therapy for Benign Prostatic Hyperplasia (BPH) 
5 Alpha-Reductase inhibitors
 • Flnasterlde and dutasterlde act by reducing
Prostatic Hyperplasia (BPH ... and dutasterlde act ... Treatment for 6 ... #Prostate #Medications ... #Pharmacology